1.555
3.67%
+0.055
Cumberland Pharmaceuticals Inc. 주식(CPIX)의 최신 뉴스
Earnings call: Cumberland Pharmaceuticals highlights steady Q1 demand - Investing.com Nigeria
Investing.com Nigeria
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q1 2024 Earnings Call Transcript - Yahoo Canada Finance
Yahoo Canada Finance
Is Cumberland Pharmaceuticals (NASDAQ:CPIX) A Risky Investment? - Yahoo Canada Shine On
Yahoo Canada Shine On
Cumberland Pharmaceuticals Inc. 2024 Q1 - Results - Earnings Call Presentation (NASDAQ:CPIX) - Seeking Alpha
Seeking Alpha
Cumberland Pharmaceuticals (NASDAQ:CPIX) Receives New Coverage from Analysts at StockNews.com - Defense World
Defense World
Cumberland Pharmaceuticals First Quarter 2024 Earnings: US$0.14 loss per share (vs US$0.013 profit in 1Q 2023) - Yahoo Finance
Yahoo Finance
Cumberland: Q1 Earnings Snapshot - Houston Chronicle
Houston Chronicle
Cumberland: Q1 Earnings Snapshot | Business & Finance | citizentribune.com - Citizentribune
Citizentribune
Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company Update - PR Newswire
PR Newswire
StockNews.com Begins Coverage on Cumberland Pharmaceuticals (NASDAQ:CPIX) - Defense World
Defense World
Poisoning Treatment Market Revenue and Size Outlook | Cumberland Pharmaceuticals, Pfizer, BTG, Novartis - Amoré
Amoré
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q4 2023 Earnings Call Transcript - Yahoo Finance
Yahoo Finance
Cumberland Pharmaceuticals Reports Annual 2023 Financial Results - PR Newswire
PR Newswire
CPIX Stock Quote Price and Forecast - CNN
CNN
Cumberland Pharmaceuticals Reports Third Quarter 2023 Financial Results - PR Newswire
PR Newswire
Asthma Market is Predicted to Exhibit Remarkable Growth by 2032, Predicts DelveInsight | Key Companies to Look Out ... - PR Newswire
PR Newswire
Cumberland Pharmaceuticals Reports Revenue and Earnings Growth Second Quarter 2023 - PR Newswire
PR Newswire
Hypertension Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - Novartis ... - PR Newswire
PR Newswire
Cumberland to launch Phase II trial of ifetroban for IPF - Clinical Trials Arena
Clinical Trials Arena
CUMBERLAND PHARMACEUTICALS ANNOUNCES FDA CLEARANCE OF IND FOR NEW TREATMENT OF ... - PR Newswire
PR Newswire
FDA approves Cumberland's therapy for fever, pain in infants - Pharmaceutical Technology
Pharmaceutical Technology
CALDOLOR® NOW FDA APPROVED FOR TREATMENT OF FEVER & PAIN IN INFANTS - PR Newswire
PR Newswire
Cumberland Pharmaceuticals Reports First Quarter 2023 Financial Results & Company Update - PR Newswire
PR Newswire
CUMBERLAND PHARMACEUTICALS REPORTS 17% REVENUE GROWTH FOR FULL YEAR 2022 - PR Newswire
PR Newswire
Health care leader Joey Jacobs dies at 69 | Health Care | nashvillepost.com - Nashville Post
Nashville Post
CUMBERLAND PHARMACEUTICALS MOVES INTO NEW HEADQUARTERS AT BROADWEST - PR Newswire
PR Newswire
Hypertension Clinical Trials Pipeline Analysis: 90+ Companies are Working to Improve the Treatment Space ... - GlobeNewswire
GlobeNewswire
CUMBERLAND PHARMACEUTICALS APPOINTS MARTIN BROWN JR. TO ITS BOARD OF DIRECTORS - PR Newswire
PR Newswire
Change Healthcare brings lawsuit against former employee | Health Care | nashvillepost.com - Nashville Post
Nashville Post
Cumberland Pharmaceuticals Announces Key Co-Promotion Agreement with Verity Pharmaceuticals to Expand ... - PR Newswire
PR Newswire
TABUK AND CUMBERLAND PARTNER TO BRING INNOVATIVE ANTIBIOTIC WITH LIFE-SAVING POTENTIAL TO ... - PR Newswire
PR Newswire
CUMBERLAND PHARMACEUTICALS ACQUIRES SANCUSO® FROM KYOWA KIRIN NORTH AMERICA - PR Newswire
PR Newswire
Cumberland Pharmaceuticals Names John Hamm New Chief Financial Officer - PR Newswire
PR Newswire
Introducing RediTrex®, A New Methotrexate Delivery System - PR Newswire
PR Newswire
Cumberland Pharmaceuticals Announces The National Launch Of A New Caldolor Ready-To-Use Product - PR Newswire
PR Newswire
FDA approves Cumberland's methotrexate products line - Pharmaceutical Technology
Pharmaceutical Technology
NYSE Chief Operating Officer John Tuttle speaks at the Cumberland Pharma Foundation’s NYSE in Nashville luncheon - The Business Journals
The Business Journals
Cumberland Pharmaceuticals Announces Strategic Review - PR Newswire
PR Newswire
The Boss: Cumberland Pharmaceuticals' A.J. Kazimi - Nashville Business Journal - The Business Journals
The Business Journals
Cumberland paying $25M+ for antibiotic | | nashvillepost.com - Nashville Post
Nashville Post
Cumberland Pharmaceuticals Inc. Trade Ideas — NASDAQ:CPIX — TradingView - TradingView
TradingView
Cumberland Pharmaceuticals Expands into Oncology Support | Markets Insider - Markets Insider
Markets Insider
Cumberland Pharmaceuticals CEO AJ Kazimi talks about his company's growth strategy - The Business Journals
The Business Journals
New Kristalose® Growth Driver Established Through Co-Promotion Agreement - PR Newswire
PR Newswire
Derivation requires showing conception and communication of idea from claimed invention, not an obvious variant ... - IPWatchdog.com
IPWatchdog.com
Aurobindo Pharma gets USFDA nod for antidote to analgesic overdose - The Economic Times
The Economic Times
자본화:
|
볼륨(24시간):